Remove 2012 Remove Blogging Remove Report Remove San Diego
article thumbnail

Walmart: Turning San Diego Into Its Technology Center

socalTECH

However, the company's technology team, Walmart Labs (www.walmartlabs.com)--which said this month that it is planning on major growth in San Diego is responsible for the company's key supply chain technology, online e-commerce site, and much more. What exactly does Walmart Labs work on in San Diego? How big are you now?

San Diego 100
article thumbnail

Walmart: Turning San Diego Into A Key Technology Center

socalTECH

However, the company's technology team, Walmart Labs (www.walmartlabs.com)--which said this month that it is planning on major growth in San Diego is responsible for the company's key supply chain technology, online e-commerce site, and much more. What exactly does Walmart Labs work on in San Diego? How big are you now?

San Diego 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pernix Therapeutics Slashes Staff to Shake Up Sales Strategy

Xconomy

As of the end of 2015, Pernix reported a headcount of 274. In 2014, Pernix, then based in The Woodlands, TX, acquired San Diego-based Somaxon Pharmaceuticals. million in net revenue last year, its highest sales mark since becoming a public company in 2010, according to its annual report. Last year, Pernix reported a $148.3

Sales 40
article thumbnail

Report: Biotech VCs Perpetuate Boardroom Gender Gap

Xconomy

In the mega-class of 177 biotechs that went public from 2012 through 2015, women held 11 percent of the board seats, according to their 2016 regulatory filings. That’s according to British recruitment firm Liftstream and its new study of biotech companies that went public in the recent boom years.

Report 40
article thumbnail

Amyloid Hypothesis Lives On—Solanezumab, Too, Despite “Siren Song”

Xconomy

When Eli Lilly (NYSE: LLY ) reported the day before Thanksgiving, that its Alzheimer’s treatment solanezumab failed to significantly improve the condition of people with a mild form of the disease , some observers immediately called it a final blow for the drug. But research continues on solanezumab; the.

News 40
article thumbnail

Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More

Xconomy

—Shares of San Diego-based Illumina (NASDAQ: ILMN ) fell more than 32 percent after the next-gen sequencing giant slashed its revenue projections once again. Illumina fended off a hostile takeover bid from Roche back in February 2012, and over the next three years shares went from about $51 apiece to as high as $219.30

News 40
article thumbnail

Despite Low Crop Prices, Corporate and VC Agtech Investments Soar

Xconomy

Venture capital firms have increased their agtech investments by 80 percent since 2012, bringing total VC investment in the sector to a total of $3 billion in 2015, according to a new report from Boston Consulting Group and AgFunder, an online investment marketplace for agriculture technology. They also queried 15 VC firms.